PRGO – Perrigo Company plc
Perrigo Company plcPRGO
$26.16Name : Perrigo Company plc
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $3,596,398,080.00
EPSttm : -1.2
Perrigo Company plc
$26.16
0.73%$0.19Float Short %
3.38
Margin Of Safety %
-11
Put/Call OI Ratio
0.13
EPS Next Q Diff
0.19
EPS Last/This Y
4.28
EPS This/Next Y
0.23
Price
26.17
Target Price
36.67
Analyst Recom
1.83
Performance Q
-5.76
Relative Volume
0.45
Beta
0.45
Ticker: PRGO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | PRGO | 26.79 | 0.19 | 0.00 | 27385 |
| 2025-05-09 | PRGO | 27 | 0.18 | 0.03 | 29376 |
| 2025-05-12 | PRGO | 27 | 0.18 | 0.88 | 29259 |
| 2025-05-13 | PRGO | 26.22 | 0.16 | 0.12 | 28991 |
| 2025-05-14 | PRGO | 26 | 0.17 | 0.82 | 28939 |
| 2025-05-15 | PRGO | 26.31 | 0.17 | 0.52 | 29007 |
| 2025-05-16 | PRGO | 27.03 | 0.15 | 0.35 | 28645 |
| 2025-05-19 | PRGO | 27.2 | 0.13 | 0.10 | 20672 |
| 2025-05-20 | PRGO | 27.43 | 0.13 | 0.06 | 20944 |
| 2025-05-21 | PRGO | 26.92 | 0.13 | 0.63 | 21047 |
| 2025-05-22 | PRGO | 26.4 | 0.13 | 0.04 | 21267 |
| 2025-05-23 | PRGO | 26.6 | 0.13 | 0.23 | 21303 |
| 2025-05-27 | PRGO | 27.34 | 0.13 | 1.44 | 21332 |
| 2025-05-28 | PRGO | 27.09 | 0.13 | 0.31 | 21403 |
| 2025-05-29 | PRGO | 27.12 | 0.13 | 0.62 | 21437 |
| 2025-05-30 | PRGO | 26.77 | 0.13 | 0.09 | 21476 |
| 2025-06-02 | PRGO | 26.71 | 0.13 | 0.10 | 21478 |
| 2025-06-03 | PRGO | 26.52 | 0.13 | 0.43 | 21520 |
| 2025-06-04 | PRGO | 26.27 | 0.13 | 0.28 | 21524 |
| 2025-06-05 | PRGO | 25.96 | 0.13 | 0.11 | 21667 |
| 2025-06-06 | PRGO | 26.16 | 0.13 | 0.69 | 21694 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | PRGO | 26.77 | 95.1 | 174.4 | 2.99 |
| 2025-05-09 | PRGO | 27.00 | 11.4 | 78.1 | 3.02 |
| 2025-05-12 | PRGO | 26.99 | 11.4 | 76.8 | 3.02 |
| 2025-05-13 | PRGO | 26.22 | 11.4 | -66.2 | 3.02 |
| 2025-05-14 | PRGO | 26.00 | 11.4 | -64.7 | 3.02 |
| 2025-05-15 | PRGO | 26.30 | 11.4 | -63.2 | 3.02 |
| 2025-05-16 | PRGO | 27.04 | 11.4 | -61.8 | 3.02 |
| 2025-05-19 | PRGO | 27.20 | 11.4 | -63.6 | 3.02 |
| 2025-05-20 | PRGO | 27.42 | 11.4 | -63.4 | 3.02 |
| 2025-05-21 | PRGO | 26.93 | 11.4 | -65.4 | 3.02 |
| 2025-05-22 | PRGO | 26.40 | 11.4 | -65.5 | 3.02 |
| 2025-05-23 | PRGO | 26.58 | 11.4 | -63.5 | 3.02 |
| 2025-05-27 | PRGO | 27.33 | 11.4 | -61.8 | 3.02 |
| 2025-05-28 | PRGO | 27.08 | 11.4 | -64.7 | 3.02 |
| 2025-05-29 | PRGO | 27.12 | 11.4 | -64.0 | 3.02 |
| 2025-05-30 | PRGO | 26.77 | 11.4 | -65.1 | 3.02 |
| 2025-06-02 | PRGO | 26.71 | 11.4 | -64.2 | 3.02 |
| 2025-06-03 | PRGO | 26.52 | 12.1 | -64.6 | 3.03 |
| 2025-06-04 | PRGO | 26.28 | 12.1 | -63.9 | 3.03 |
| 2025-06-05 | PRGO | 25.97 | 12.1 | -64.0 | 3.03 |
| 2025-06-06 | PRGO | 26.17 | 12.1 | -62.6 | 3.03 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | PRGO | -3.97 | 1.83 | 3.58 |
| 2025-05-09 | PRGO | -3.97 | 1.83 | 3.58 |
| 2025-05-12 | PRGO | -3.94 | 1.43 | 3.81 |
| 2025-05-13 | PRGO | -3.94 | 1.43 | 3.81 |
| 2025-05-14 | PRGO | -3.42 | 1.43 | 3.81 |
| 2025-05-15 | PRGO | -3.42 | 1.43 | 3.81 |
| 2025-05-16 | PRGO | -3.42 | 1.43 | 3.81 |
| 2025-05-19 | PRGO | -3.42 | -0.61 | 3.81 |
| 2025-05-20 | PRGO | -3.15 | -0.61 | 3.81 |
| 2025-05-21 | PRGO | -3.15 | -0.61 | 3.81 |
| 2025-05-22 | PRGO | -3.15 | -0.61 | 3.81 |
| 2025-05-23 | PRGO | -3.15 | -0.61 | 3.81 |
| 2025-05-27 | PRGO | -3.15 | 0.84 | 3.81 |
| 2025-05-28 | PRGO | -3.15 | 0.84 | 3.38 |
| 2025-05-29 | PRGO | -3.15 | 0.84 | 3.38 |
| 2025-05-30 | PRGO | -3.15 | 0.84 | 3.38 |
| 2025-06-02 | PRGO | -3.15 | 0.93 | 3.38 |
| 2025-06-03 | PRGO | -3.15 | 0.93 | 3.38 |
| 2025-06-04 | PRGO | -3.15 | 0.93 | 3.38 |
| 2025-06-05 | PRGO | -3.15 | 0.93 | 3.38 |
| 2025-06-06 | PRGO | -3.15 | 0.93 | 3.38 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.6
Avg. EPS Est. Current Quarter
0.59
Avg. EPS Est. Next Quarter
0.79
Insider Transactions
-3.15
Institutional Transactions
0.93
Beta
0.45
Average Sales Estimate Current Quarter
1082
Average Sales Estimate Next Quarter
1113
Fair Value
23.29
Quality Score
51
Growth Score
48
Sentiment Score
16
Actual DrawDown %
55.5
Max Drawdown 5-Year %
-54.1
Target Price
36.67
P/E
Forward P/E
7.98
PEG
P/S
0.83
P/B
0.82
P/Free Cash Flow
19.86
EPS
-1.27
Average EPS Est. Cur. Y
3.03
EPS Next Y. (Est.)
3.26
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-4.02
Relative Volume
0.45
Return on Equity vs Sector %
-28.2
Return on Equity vs Industry %
-12
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
-62.6
Perrigo Company plcSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 8379
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
stock quote shares PRGO – Perrigo Company plc Stock Price stock today
news today PRGO – Perrigo Company plc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRGO – Perrigo Company plc yahoo finance google finance
stock history PRGO – Perrigo Company plc invest stock market
stock prices PRGO premarket after hours
ticker PRGO fair value insiders trading